Research Article
miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma
Table 4
The relationship between miR-149-3p target gene expression level and prognosis.
| Gene name | HR | CI | P value |
| PLCE1 | 0.49 | 0.318–0.754 | 0.001 | DNAH9 | 0.66 | 0.437–0.997 | 0.048 | ADCYAP1R1 | 0.655 | 0.433–0.991 | 0.045 | RARA | 0.622 | 0.408–0.949 | 0.027 | IGF1 | 0.62 | 0.409–0.939 | 0.024 | CYGB | 0.597 | 0.394–0.905 | 0.015 | CHST3 | 0.638 | 0.421–0.967 | 0.034 | HIC1 | 0.623 | 0.412–0.943 | 0.025 | INMT | 0.603 | 0.397–0.916 | 0.018 | CGNL1 | 0.616 | 0.406–0.934 | 0.022 | NFIC | 0.499 | 0.326–0.765 | 0.001 | ESR1 | 0.519 | 0.339–0.795 | 0.003 | HHIP | 0.659 | 0.437–0.993 | 0.046 | HOXD11 | 0.65 | 0.430–0.984 | 0.042 | ZBTB7A | 0.613 | 0.404–0.932 | 0.022 | SPRYD3 | 0.641 | 0.423–0.972 | 0.036 | MTMR10 | 0.617 | 0.406–0.936 | 0.023 | LSP1 | 0.503 | 0.328–0.771 | 0.002 | SNTN | 0.613 | 0.406–0.925 | 0.020 |
|
|